Subscribe To
Roche settles us patent lawsuit against biogen over blockbuster arthritis drug
Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster ...
October 23, 2023, 3:28 pm
Global rheumatoid arthritis market poised for us$ 1.2 billion by 2033: growing prevalence of rheumatoid arthritis boosts market growth, according to persistence market research
Key market drivers of rheumatoid Arthritis Market: rising prevalence, increased demand for treatments, ...
October 12, 2023, 12:10 pm
Aclaris therapeutics: the many lives of this biopharmaceutical developer
Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...
September 28, 2023, 7:18 am
Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations
Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...
August 29, 2023, 7:50 am
Biosimilar contract manufacturing market size to hit usd 26.1 billion by 2032 at 18.90% cagr – report by market research future (mrfr)
Biosimilar Contract Manufacturing Market Trends and Insights By Product (Recombinant Non-glycosylated Proteins and Recombinant Glycosylated Proteins),...
July 24, 2023, 11:34 am
Kiniksa pharmaceuticals: autoimmune therapy offers attractive prospects at current price
Innovations in the drug lineup, including ARCALYST, KPL-404, and Mavrilimumab, showcase Kiniksa's dedication to targeting challenging autoimmune and i...
July 19, 2023, 3:25 pm
Aclaris therapeutics: q4 of 2023 catalyst makes this a must watch
Aclaris Therapeutics, Inc. results from a phase 2b study using zunsemetinib for the treatment of patients with ...
July 11, 2023, 7:31 pm
: organon and samsung bioepis launch humira biosimilar hadlima in the u.s.
Organon & Co. OGN and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move comes af...
July 5, 2023, 11:39 am
Abbvie braces for increased humira competition from cheaper biosimilar
AbbVie is about to face stiffer competition for its blockbuster rheumatoid arthritis drug Humira from a...
July 5, 2023, 10:14 am
Celltrion launches biosimilar of abbvie's blockbuster drug humira in us
South Korea's Celltrion Healthcare has launched a copycat version to AbbVie Inc's Humira at about a 5% discount, adding to the growing competition for...
July 5, 2023, 7:34 am
Organon and samsung bioepis launch humira biosimilar hadlima in the u.s.
Organon & Co. OGN, -1.15% and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move ...
July 5, 2023, 6:45 am
India's biocon biologics launches biosimilar for abbvie's humira in us
India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoi...
July 3, 2023, 1:59 pm
Fresenius launches biosimilar version of abbvie's humira at 5% discount
The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling ...
July 3, 2023, 10:59 am
For abbvie's blockbuster humira, cheaper competitors pose surprisingly little threat, analysts say
AbbVie's ABBV, +1.53% rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical produc...
June 30, 2023, 1:28 pm
Abbvie, coherus agree to resolve dispute over humira biosimilar
Coherus BioSciences Inc said on Thursday it had agreed to resolve a dispute over its plans to launch a lower-priced version of AbbVie Inc's Humira, it...
June 15, 2023, 7:10 am
Why aclaris therapeutics topped the market on tuesday
The biotech has completed enrollment in the next phase of an important development program. It is aiming to get a ...
June 13, 2023, 6:30 pm
Dr. reddy's (rdy) meets goals in actemra biosimilar study
Dr. Reddy's (RDY) announces meeting primary and secondary endpoints in the phase I study of its proposed tocilizumab biosimilar for the treatment of <...
June 6, 2023, 7:59 am
Galapagos stands strong on jyseleca positive clinical data
Galapagos' focuses on immunology and oncology, with its flagship Jyseleca being used to treat rheumatoid...
May 6, 2023, 1:59 am
Nurix's stock rallies on gilead's option
Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercise...
March 20, 2023, 9:00 am
[trending] global rheumatoid arthritis drugs market size & share to hit $ 70.1 billion by 2030 at a 1.75% cagr: growing cases of rheumatoid arthritis to propel market demand- facts & factors
The global rheumatoid arthritis drugs market size was valued at USD 60.1 billion in 2021 and is expecte...
February 10, 2023, 9:10 am